Molecular Approaches to Safe and Controlled Engineered T-cell Therapy

Chimeric antigen receptor-modified T-cell therapy (CAR-T therapy) is one of the fastest developing areas of immuno-oncology. Over the past decade, it has revolutionized the cell therapy modality and expedited its pace of development, from optimization of the structure of chimeric antigen receptors a...

Descripción completa

Detalles Bibliográficos
Autores principales: Kalinin, R. S., Petukhov, A. V., Knorre, V. D., Maschan, M. A., Stepanov, A. V., Gabibov, A.G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: A.I. Gordeyev 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6087824/
https://www.ncbi.nlm.nih.gov/pubmed/30116611

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6087824/
https://www.ncbi.nlm.nih.gov/pubmed/30116611

Ejemplares similares